Won Jong Chul, Hong Jae Won, Kim Jung Min, Kim Tae Nyun, Noh Jung Hyun, Ko Kyung Soo, Rhee Byoung Doo, Kim Dong-Jun
Department of Internal Medicine, Sanggye Paik Hospital, Cardiovascular and Metabolic Disease Center, College of Medicine, Inje University, Seoul, Republic of Korea.
Department of Internal Medicine, Ilsan-Paik Hospital, College of Medicine, Inje University, Koyang, Republic of Korea.
J Diabetes Complications. 2015 Jan-Feb;29(1):50-4. doi: 10.1016/j.jdiacomp.2014.08.006. Epub 2014 Aug 27.
We investigated the prevalence of albuminuria across a range of fasting plasma glucose (FPG), including normal fasting glucose (NFG), impaired fasting glucose (IFG), and diabetes.
A total of 5202 subjects who participated in the fifth Korea National Health and Nutrition Examination Survey were enrolled. Spot urine samples were taken and the albumin-creatinine ratio was calculated for each patient. Subjects were divided into five groups according to FPG levels: <5.0 (NFG1, n=1,905), 5.0-5.5 (NFG2, n=1,784), 5.6-6.0 (IFG1, n=727), 6.1-6.9 (IFG2, n=268), and ≥7.0 (diabetes, n=518) mmol/L. Analysis of covariance tests and logistic regression were used.
The rates of albuminuria were 4.1%, 6.0%, 7.6%, 12.3%, and 23.4% in the NFG1, NFG2, IFG1, IFG2 and diabetes groups, respectively (P<0.01 for the trend). The rate of albuminuria in the IFG2 group was significantly higher than in the IFG1 group, even after adjustment for age, gender, hypertension, and obesity. The odds ratio for the presence of albuminuria in the IFG2 group was 1.87 (95% CI, 1.19-2.94), using the NFG1 group as a control in logistic regression analyses.
Albuminuria is more prevalent in subjects in the higher range of IFG. Therefore, strategies to reduce albuminuria should be emphasized especially in these subjects.
我们调查了一系列空腹血糖(FPG)水平(包括正常空腹血糖(NFG)、空腹血糖受损(IFG)和糖尿病)人群中蛋白尿的患病率。
共有5202名参与第五次韩国国家健康与营养检查调查的受试者被纳入研究。采集即时尿样并计算每位患者的白蛋白肌酐比值。根据FPG水平将受试者分为五组:<5.0(NFG1,n = 1905)、5.0 - 5.5(NFG2,n = 1784)、5.6 - 6.0(IFG1,n = 727)、6.1 - 6.9(IFG2,n = 268)和≥7.0(糖尿病,n = 518)mmol/L。采用协方差分析检验和逻辑回归分析。
NFG1、NFG2、IFG1、IFG2和糖尿病组的蛋白尿发生率分别为4.1%、6.0%、7.6%、12.3%和23.4%(趋势P<0.01)。即使在调整年龄、性别、高血压和肥胖因素后,IFG2组的蛋白尿发生率仍显著高于IFG1组。在逻辑回归分析中,以NFG1组作为对照,IFG2组出现蛋白尿的优势比为1.87(95%CI,1.19 - 2.94)。
蛋白尿在较高范围的IFG人群中更为普遍。因此,应特别强调在这些人群中采取减少蛋白尿的策略。